Keywords: AASLD; American Association for the Study of the Liver Disease; AFP; α-fetoprotein; ALT; alanine aminotransferase; AST; aspartase aminotransferase; AFP-L3; agglutinin reactive fraction of AFP; cccDNA; covalently closed circular DNA; CTL; cytotoxic T lymp
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Hepatitis B virus (HBV); Viral targets; Direct acting agents (DAA); HBV cure; cccDNA;
Keywords: AIDS; acquired immune deficiency syndrome; ALV; avian leukosis virus; AMV; avian myeloblastosis virus; APOBEC; apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like; ASLV; avian sarcoma leukosis virus; AZT; 3â² -azido-3â² -deoxythymidine; BIV;
Keywords: Hepatitis B; Guidelines; Antiviral Therapy; Peginterferon alfa-2a; Entecavir; Tenofovir; Resistance; AFP; alpha-fetoprotein; ALT; alanine aminotransferase; anti-HBc; antibody to hepatitis B core antigen; anti-HBe; antibody to hepatitis B e antigen; anti-H
St6gal1 knockdown alters HBV life cycle in HepAD38 cells
Keywords: Hepatitis B virus; N-glycan; Sialylated N-glycan; Complex-type N-glycan; HBV; Hepatitis B virus; SVP; Sub-viral particle; WT; Wild-type; Tet(+); Tetracycline-supplemented; Tet(â); Tetracycline-free; ER; Endoplasmic reticulum; St6gal1; β-galactoside α2
Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia
Keywords: cccDNA; covalently closed circular DNA; HBV; hepatitis B virus; HCV; hepatitis C virus;
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy
Keywords: cccDNA; Chronic hepatitis B; HBcrAg; HBsAg; Hepatitis B core-related antigen; Hepatitis B virus; Pegylated interferon; Predictor; Stopping rule; Treatment response;
Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners
Keywords: HBV cccDNA; Transcription factor; Epigenetic regulation; ZHX2; Zinc finger and homeoboxes 2; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBcAg; hepatitis B core antigen;
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
Keywords: CHB; chronic hepatitis B; HBV; hepatitis B virus; NA; nucleos(t)ide analogue; cccDNA; covalently closed circular DNA; guide RNA; gRNA; NTCP; sodium taurocholate cotransporting polypeptide; RC-DNA; relaxed circular DNA; pgRNA; pregenomic RNAs; HBsAg; HBV s
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus
Keywords: HBV; HCV; CRISPR/Cas; cccDNA; Gene therapy;
Identification of Slug and SOX7 as transcriptional repressors binding to the hepatitis B virus core promoter
Keywords: HBV; Slug; SOX7; Hepatocytes; Liver; Transcription; HNF4α; pgRNA; cccDNA; Promoter; Repression;
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
Keywords: TLR7; GS-9620; Hepatitis B virus; Interferon-alpha; cccDNA; Interferon-stimulated gene; MHC; Immunoproteasome; APOBEC; Smc5/6;
Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy
Keywords: Hepatitis B virus; Chronic hepatitis B; Hepadnaviridae; Vertical transmission; Viral life cycle; p22cr; 22-kDa core-related protein; anti-HBc; anti hepatitis B core protein antibodies; Alix; apoptosis linked gene II interacting protein X; ARD; arginine-ri
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection
Keywords: CAM; ER Stress Response; Assembly Inhibitor Core Protein; Replication; DAA; ALT; alanine aminotransferase; CAM; capsid assembly modulator; cccDNA; covalently closed circular DNA; ER; endoplasmatic reticulum; ETV; entecavir; h-Alb; human albumin; HAP; hete
Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients
Keywords: Hepatitis B virus core protein; Chronic hepatitis B; Deep sequencing; HBeAg status; Treatment response; HBV; hepatitis B virus; CHB; chronic hepatitis B; NUC; nucleos(t)ide analogues; peg-IFN; pegylated interferon; HBsAg; hepatitis B surface antigen; HBc;
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3
Keywords: Antiviral; Immune Response; Immune Therapy; LTB; 3-D; 3-dimensional; AE-T; activated T; APOBEC3; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3; CAR; chimeric antigen receptor; cccDNA; covalently closed circular DNA; E:T; effector cell-to
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
Keywords: Coinfection; Interferon-stimulated Gene; PRR; RIG-I; APOBEC; apolipoprotein B mRNA editing enzyme catalytic subunit; cccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; circDNA; circular DNA; GFP-IRF3; green fluorescent protein-interferon
Humanized chimeric mouse models of hepatitis B virus infection
Keywords: HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; SCID; severe combined immunodeficiency; alb-uPA; albumin-promoted urokinase-type plasminogen activator; RAG2; recombinant activation gene 2; RI; repopulation index; FAH; fumarylacetoacetate h
Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector
Keywords: Hepatitis B virus; cccDNA; Adeno-associated virus; Immune-competent mouse; Immune-therapeutics; AAV; adeno-associated virus; cccDNA; covalently closed circular DNA; DIG; digoxigenin; dsl; double stranded linear DNA; HBV; Hepatitis B Virus; HDV; Hepatitis
Animal models of HBV infection
Keywords: Animal models; HBV-related viruses; Hepadnaviruses; Humanized mice; Antiviral therapy; Immunopathogenesis; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; pgRNA; pregenomic RNA; DHBV; duck hepatitis B virus; WHV; woodchuck hepatitis virus;
Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC
Keywords: Hepatitis B virus; cccDNA; Mutation; Survival; Hepatocellular carcinoma;
Impact of hepatitis B vaccination on HBsAg kinetics, interferon-inducible protein 10 level and recurrence of viremia
Keywords: CccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; ECLIA; Electrochemiluminescence immunoassay; ELISA; Enzyme-linked immunosorbent assay; HBsAg; HBV surface antigen; HCC; hepatocellular carcinoma; HOMA-IR; Homeostatic model assessment for i
Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome
Keywords: Hepatitis B virus; Hepatitis B core protein; HBV transcription; Histone acetylation; Covalently closed circular DNA; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; HBc; hepatitis B core protein; CTD; C-terminal domain; pgRNA; pregenomic R
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients
Keywords: Peginterferon alfa-2a; Adefovir; Ultra-deep pyrosequencing; Mutation; Hepatitis B e antigen; Response marker; 454 DS; 454 deep sequencing; ALT; alanine aminotransferase; BCP; basal core promoter; cccDNA; covalently closed circular DNA; CHB; chronic hepati
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
Keywords: HBV; Intrahepatic innate immune response; cccDNA; HBsAg;
Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells
Keywords: HBV; cccDNA; PRPF31;
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication
Keywords: Hepatitis B Virus Infection; STAT3 Signaling; Hepatocellular Carcinoma; Apoptosis; APR; acute phase response; cDNA; complementary DNA; cccDNA; covalently closed circular DNA; cRNA; complementary RNA; CRP; C-reactive protein; DMSO; dimethyl sulfoxide; FCS;
Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector
Keywords: Sulfamoylbenzamide; Antiviral agent; HBV; Capsid assembly effector; cccDNA; HBeAg;
Treatment of hepatitis B virus with combination therapy now and in the future
Keywords: Combination therapy; Hepatitis B; Immunotherapy; Immunomodulators; Direct acting antivirals (DAA); Antiviral therapy; cccDNA;
Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection
Keywords: Chronic hepatitis B; Antiviral therapy; IFN signaling pathway; STAT1; MX; Peg-IFN; pegylated interferon; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; NAs; nucleot(s)ide analogues; CHB; chronic hepatitis B; ETV; entecavir; ISGs; interf
Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription
Keywords: Hepatitis B virus; Sirtuin; HBx; cccDNA; SIRT1;
Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver
Keywords: NK Cell; CXCL10; Mouse Model; IL10; HBe; cccDNA; covalently closed circular DNA; CHB; chronically HBV infected; ELISA; enzyme-Linked Immunosorbent Assay; ETV; entecavir; hAlb; human Albumin; HBcAg; hepatitis B core antigen; HBe; hepatitis B envelope; HBs;
Exploring the potential of genome editing CRISPR-Cas9 technology
Keywords: Cas; CRISPR-associated proteins; cccDNA; covalently closed circular DNA; CCR5; C-C chemokine receptor type 5; CHO; Chinese hamster ovary; CRISPRs; clustered regularly interspaced short palindromic repeats; CRISPRa; CRISPR activation; CRISPRi; CRISPR inter
Two-way molecular ligation for efficient conversion of monomeric hepatitis B virus DNA constructs into tandem dimers
Keywords: cccDNA; covalently closed circular DNA; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; pg RNA; pregenomic RNA; Hepatitis B virus; Covalently closed circular DNA; Tandem dimer; Prege
Improved antiviral efficacy using TALEN-mediated homology directed recombination to introduce artificial primary miRNAs into DNA of hepatitis B virus
Keywords: HBV; TALEN; Artificial primary miRNA; cccDNA;
Variability in long-term hepatitis B virus dynamics under antiviral therapy
Keywords: CccDNA; Pegylated interferon alpha; Adefovir dipivoxil; Viral dynamics; Mathematical modelling
CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
Keywords: CRISPR/Cas9; HBV; cccDNA; Hydrodynamics;
Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1
Keywords: SAMHD1; HBV restriction; dNTPase; cccDNA;
Research ArticleIn vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
Keywords: HBV; hepatitis B virus; ASO; antisense oligonucleotide; HBsAg; hepatitis B surface antigen; HCC; hepatocellular carcinoma; NTCP; sodium taurocholate cotransporting polypeptide; cccDNA; circular covalently closed DNA; RT; reverse transcriptase; HBcAg; hepa
Research ArticleHBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics
Keywords: CHB; chronic hepatitis B; HCC; hepatocellular carcinoma; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; BCP; basal core promoter; HBcrAg; hepatitis B virus core-related antigen; cccDNA; covalently closed circular
Research ArticleTreatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; bovine serum albumin; blq; below limit of quantification; cccDNA; covalently closed circular deoxyribonucleic acid; CHB; chronic hepatitis B; CHD; chronic hepatitis D; d; hepatocyte deat
Research ArticleNovel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection
Keywords: HBV; hepatitis B virus; ETV; entecavir; MEND; pH-sensitive multifunctional envelope-type nanodevice; cccDNA; covalently closed circular DNA; HBsAg; hepatitis B virus surface antigen; HBeAg; hepatitis B virus e antigen; HBcAg; hepatitis B virus core antige
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
Keywords: HBV; hepatitis B virus; cccDNA; covalently-closed circular DNA; IH-DNA; intrahepatic DNA; HIV; human immunodeficiency virus; HBeAg; hepatitis B “e” antigen; IQR; interquartile range; TDF; tenofovir; HCC; hepatocellular carcinoma; NA; nucleoside/nucleo
EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes
Keywords: cccDNA; circular covalently closed DNA; EpCAM; epithelial cell adhesion molecule; EpICD; EpCAM intracellular domain; hCSCs; hepatic cancer stem cells; HBV; hepatitis B virus; HBc; hepatitis B virus core antigen; HCC; hepatocellular carcinoma; PRC2; polyco
Original ResearchFull Report: Basic and Translational-LiverInterferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis
Keywords: Apolipoprotein B mRNA Editing Enzyme; HBV Persistence; T-Cell Receptor; Immune Regulation; 3D-PCR; differential DNA denaturation PCR; A3; APOBEC3; ALT; alanine aminotransferase; AP; apurinic/apyrimidinic; cccDNA; covalently closed circular DNA; Cp; crossi
Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators
Keywords: Hepatitis B virus; cccDNA; HBeAg; High throughput screening;
Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities
Keywords: HBV cure; siRNA; CRISPR/Cas9; Anti-HBV agents; cccDNA; HBsAg; Antiviral therapy;
Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo
Keywords: Hepatitis B virus; HBV vector; RNAi; Chronic hepatitis B; HBV transgenic mice; shRNA delivery; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; CMV-IE; cytomegalovirus immediate early; dsL; double-stranded linear; FACS; fluorescence-activat
Hepatitis B virus (HBV) X protein-mediated regulation of hepatocyte metabolic pathways affects viral replication
Keywords: HBV; Hepatitis B virus; HCC; Hepatocellular carcinoma; HBx; HBV X protein; cccDNA; Covalently closed circular DNA; ORF; Open reading frame; mTORC1; Mammalian target of rapamycin (mTOR) complex 1; TSC2; Tuberous-sclerosis complex-2; AMPK; AMP-activated pro